Código QR (código de barras bidimensional)

SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP

Background: Direct oral anticoagulants (DOACs) are widely used for the treatment and secondary prophylaxis of venous thromboembolism (VTE). Nowadays, DOACs represent the gold standard for long-term anticoagulation, with low-intensity DOACs administration becoming increasingly used worldwide in such...

Fuld beskrivelse

Na minha lista:
Principais autores: Alessandro Laganà, Giovanni Manfredi Assanto, Chiara Masucci, Mauro Passucci, Livia Donzelli, Alessandra Serrao, Erminia Baldacci, Cristina Santoro, Antonio Chistolini
Format: Artigo
Sprog:Inglês
Udgivet: PAGEPress Publications 2024-02-01
Serier:Mediterranean Journal of Hematology and Infectious Diseases
Fag:
dose-reduced
Deep vein thrombosis
Direct oral anticoagulants (DOACs)
Venous thromboembolism secondary prophylaxis
VTE recurrence
Bleeding adverse events
Online adgang:https://www.mjhid.org/mjhid/article/view/5567
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker